Tati, Claribel .

HRN: 28-17-28  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2025
CEFUROXIME 500MG (TAB)
12/20/2025
12/27/2025
ORAL
500 Mg/tab
BID
S/p D&C
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines